Lucknow : In the ongoing investigation against fake medicines and fake billing, the Food Safety and Drug Administration (FSDA) has hit hard at Aminabad, the biggest market of medicines in Lucknow, the capital of UP. Of the establishments that came under the scanner of FSDA, the pharmaceutical licenses of 14 have been cancelled, while the licenses of 29 are suspended. The decision on five firms is still pending.
Read :- Houses and markets will be illuminated from village to metropolis on Dussehra-Diwali, UPPCL intensified preparations.
During FSDA investigation, the establishments whose licenses were canceled were found to be involved in cross-billing and the business of counterfeit medicines. At the same time, action has been taken against the establishments whose licenses have been suspended due to shortcomings found in the investigation by FSDA.
Link related to the investigation in August
In August, FSDA investigation had revealed that some firms linked to Aminabad were selling fake and counterfeit medicines in the market by showing sales and purchases on paper. M/s Health Plus, M.K. A total of nine FIRs were registered under various sections of the Indian Justice Code at Aminabad police station on August 12 against other firms including Pharma, Ram Pharma and Patient Care Surgical House of Saharanpur.
Fake medicines were seized from illegal warehouse
Read :- No goon-mafia can capture any property in UP, if he does then the earnings of his forefathers will also be confiscated and houses for the poor will be built: Yogi
In July, fake medicines were seized from an illegal warehouse in Alambagh, Bakshi Ka Talab and Aminabad in Lucknow. FIR was registered against eight firms and a software vendor of Aminabad on charges of fake billing and software manipulation, while in Kesarbagh, a cross-billing syndicate without physical supply was exposed. According to the department, till now illegal drugs worth Rs 41.58 lakh have been seized in Lucknow and nine FIRs have been registered against 32 people. Of which two have been arrested.
Licenses of 14 establishments canceled
In continuation of this action, now Health Plus, M.K. The licenses of Pharma and Ram Pharma have been cancelled. Apart from these, Shri Banke Bihari Pharma, New Baba Pharma, Chhota Pharma, Bharat Pharma, Vidya Pharma, Shri Ashok Pharmaceutics, M.D.H. Licenses of Pharma, Shri Raj Rajeshwar Enterprises and Supervision Traders have also been cancelled. The same action has been taken at the main establishment of Mishra Associates and its warehouse. According to the checklist, a warehouse of Mishra Associates was operating without a license.
Licenses of 29 establishments suspended
The establishments whose licenses have been suspended include SS Medico, Mahalaxmi Traders, Trademed India Pvt (two firms), Medtras Multiverse, Pharma Sales, Sukhmani Pharma, Bapu Medical Hall, Anant Enterprises, Sanskriti Pharma, Om Sai Ram Medicos (warehouse), Rudraksh Pharma and Durga Distributors (main firm and warehouse). Along with these, Bhagwati Enterprises, Jai Shree Mahakal Pharmaceuticals, Mac Pharma, Sri Tirupati Balaji Agency, RG Pharma, Anantasia Pharma Pvt. Ltd., Sonal Pharma, Gayatri Pharma & Surgicals, SKG Medicals, Ma Ambe Pharma, Shree Ashtavinayak Pharmaceuticals, AS Medical Stores, SP Pharma, Durva International and RN Pharma are also suspended. These establishments will not be able to buy and sell medicines during the suspension period.
Read: First theft of donations, then theft of offerings, then theft of votes and now theft of wages of poor labourers: Aradhana Mishra
Decision pending on five firms
Show cause notices were issued to Vinod Pharmaceuticals Distributors, Shree Krishna Pharmaceuticals Distributors, Raj & Brothers Pharma, Guruji Pharmaceuticals and Sun Light Pharma, but the final decision in their cases is still pending. The locations of these five firms are also in Aminabad.
Indications that the campaign will continue
There is panic among the businessmen due to the action being taken against so many establishments simultaneously in the drug market of Aminabad. The department has said that the campaign against counterfeit medicines and fraudulent billing networks will continue.